Assessing ageing of individual T lymphocytes: Mission impossible?

Mechanisms of Ageing and Development

Volumn 129, Issue 1-2, 2008, Pages 67-78

  Iancu, Emanuela M ^a   Speiser, Daniel E ^b   Rufer, Nathalie ^a  

^a Multidisciplinary Oncology Center (CePO)   (Switzerland)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

Author keywords

Ageing; Antigen specific; Human; Immunotherapy; Memory; Naive; Replicative senescence; T cell clonotypes; T cell differentiation; T lymphocytes; Telomeres

Indexed keywords

AGING; ARTICLE; CANCER PATIENT; CELL AGING; CELL COUNT; CELL CULTURE; CELL DIVISION; CELL FUNCTION; CELL POPULATION; CELL PROLIFERATION; CELL TRANSFER; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; INFECTION; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; SENESCENCE; T LYMPHOCYTE; TELOMERE; VACCINATION;

ADOPTIVE TRANSFER; AGING; ANIMALS; CELL AGING; CELL DIFFERENTIATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICE; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TELOMERE; VACCINES;

EID: 38849154490     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2007.10.005     Document Type: Article

References (124)

1. Ahmed R., and Gray D. Immunological memory and protective immunity: understanding their relation. Science 272 (1996) 54-60
2. Allshire R.C., Gosden J.R., Cross S.H., Cranston G., Rout D., Sugawara N., Szostak J.W., Fantes P.A., and Hastie N.D. Telomeric repeat from T. thermophila cross hybridizes with human telomeres. Nature 332 (1988) 656-659
3. Allsopp R.C., Vaziri H., Patterson C., Goldstein S., Younglai E.V., Futcher A.B., Greider C.W., and Harley C.B. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 10114-10118
4. Alter B.P., Baerlocher G.M., Savage S.A., Chanock S.J., Weksler B.B., Willner J.P., Peters J.A., Giri N., and Lansdorp P.M. Very short telomere length by flow FISH identifies patients with Dyskeratosis Congenita. Blood 110 (2007) 1439-1447
5. Altman J.D., Moss P.A., Goulder P.J., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J., and Davis M.M. Phenotypic analysis of antigen-specific T lymphocytes. Science 274 (1996) 94-96
6. Appay V., Dunbar P.R., Callan M., Klenerman P., Gillespie G.M., Papagno L., Ogg G.S., King A., Lechner F., Spina C.A., Little S., Havlir D.V., Richman D.D., Gruener N., Pape G., Waters A., Easterbrook P., Salio M., Cerundolo V., McMichael A.J., and Rowland-Jones S.L. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8 (2002) 379-385
7. Baerlocher G.M., and Lansdorp P.M. Telomere length measurements in leukocyte subsets by automated multicolor flow-FISH. Cytometry A 55 (2003) 1-6
8. Baerlocher G.M., and Lansdorp P.M. Telomere length measurements using fluorescence in situ hybridization and flow cytometry. Methods Cell. Biol. 75 (2004) 719-750
9. Baerlocher G.M., Mak J., Tien T., and Lansdorp P.M. Telomere length measurement by fluorescence in situ hybridization and flow cytometry: tips and pitfalls. Cytometry 47 (2002) 89-99
10. Baerlocher G.M., Rice K., Vulto I., and Lansdorp P.M. Longitudinal data on telomere length in leukocytes from newborn baboons support a marked drop in stem cell turnover around 1 year of age. Aging Cell 6 (2007) 121-123
11. Baerlocher G.M., Vulto I., de Jong G., and Lansdorp P.M. Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nat. Protoc. 1 (2006) 2365-2376
12. Baird D.M., Rowson J., Wynford-Thomas D., and Kipling D. Extensive allelic variation and ultrashort telomeres in senescent human cells. Nat. Genet. 33 (2003) 203-207
13. Batliwalla F.M., Damle R.N., Metz C., Chiorazzi N., and Gregersen P.K. Simultaneous flow cytometric analysis of cell surface markers and telomere length: analysis of human tonsilar B cells. J. Immunol. Methods 247 (2001) 103-109
14. Batliwalla F.M., Rufer N., Lansdorp P.M., and Gregersen P.K. Oligoclonal expansions in the CD8(+)CD28(-) T cells largely explain the shorter telomeres detected in this subset: analysis by flow FISH. Hum. Immunol. 61 (2000) 951-958
15. Ben-Porath I., and Weinberg R.A. When cells get stressed: an integrative view of cellular senescence. J. Clin. Invest. 113 (2004) 8-13
16. Bigouret V., Hoffmann T., Arlettaz L., Villard J., Colonna M., Ticheli A., Gratwohl A., Samii K., Chapuis B., Rufer N., and Roosnek E. Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors. Blood 101 (2003) 3198-3204
17. Bodnar A.G., Kim N.W., Effros R.B., and Chiu C.P. Mechanism of telomerase induction during T cell activation. Exp. Cell Res. 228 (1996) 58-64
18. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., and Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science 279 (1998) 349-352
19. Boon T., Coulie P.G., Van den Eynde B.J., and Van der Bruggen P. Human T cell responses against melanoma. Annu. Rev. Immunol. 24 (2006) 175-208
20. Buchkovich K.J., and Greider C.W. Telomerase regulation during entry into the cell cycle in normal human T cells. Mol. Biol. Cell 7 (1996) 1443-1454
21. Callan M.F., Steven N., Krausa P., Wilson J.D., Moss P.A., Gillespie G.M., Bell J.I., Rickinson A.B., and McMichael A.J. Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat. Med. 2 (1996) 906-911
22. Callan M.F., Tan L., Annels N., Ogg G.S., Wilson J.D., O'Callaghan C.A., Steven N., McMichael A.J., and Rickinson A.B. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J. Exp. Med. 187 (1998) 1395-1402
23. Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell. Biol. 11 (2001) S27-S31
24. Cerottini J.C., and MacDonald H.R. The cellular basis of T-cell memory. Annu. Rev. Immunol. 7 (1989) 77-89
25. Chang S., Multani A.S., Cabrera N.G., Naylor M.L., Laud P., Lombard D., Pathak S., Guarente L., and DePinho R.A. Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nat. Genet. 36 (2004) 877-882
26. d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., and Jackson S.P. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426 (2003) 194-198
27. Dagarag M., Evazyan T., Rao N., and Effros R.B. Genetic manipulation of telomerase in HIV-specific CD8+ T cells: enhanced antiviral functions accompany the increased proliferative potential and telomere length stabilization. J. Immunol. 173 (2004) 6303-6311
28. Dagarag M., Ng H., Lubong R., Effros R.B., and Yang O.O. Differential impairment of lytic and cytokine functions in senescent human immunodeficiency virus type 1-specific cytotoxic T lymphocytes. J. Virol. 77 (2003) 3077-3083
29. Davis T., and Kipling D. Telomeres and telomerase biology in vertebrates: progress towards a non-human model for replicative senescence and ageing. Biogerontology 6 (2005) 371-385
30. Derre L., Bruyninx M., Baumgaertner P., Devevre E., Corthesy P., Touvrey C., Mahnke Y.D., Pircher H., Voelter V., Romero P., Speiser D.E., and Rufer N. In vivo persistence of codominant human CD8+ T cell clonotypes is not limited by replicative senescence or functional alteration. J. Immunol. 179 (2007) 2368-2379
31. Dudley M.E., Wunderlich J., Nishimura M.I., Yu D., Yang J.C., Topalian S.L., Schwartzentruber D.J., Hwu P., Marincola F.M., Sherry R., Leitman S.F., and Rosenberg S.A. Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma. J. Immunother. 24 (2001) 363-373
32. Dudley M.E., Wunderlich J.R., Yang J.C., Sherry R.M., Topalian S.L., Restifo N.P., Royal R.E., Kammula U., White D.E., Mavroukakis S.A., Rogers L.J., Gracia G.J., Jones S.A., Mangiameli D.P., Pelletier M.M., Gea-Banacloche J., Robinson M.R., Berman D.M., Filie A.C., Abati A., and Rosenberg S.A. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J. Clin. Oncol. 23 (2005) 2346-2357
33. Effros R.B., Allsopp R., Chiu C.P., Hausner M.A., Hirji K., Wang L., Harley C.B., Villeponteau B., West M.D., and Giorgi J.V. Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 10 (1996) F17-F22
34. Effros R.B., and Pawelec G. Replicative senescence of T cells: does the Hayflick limit lead to immune exhaustion?. Immunol. Today 18 (1997) 450-454
35. Egholm M., Buchardt O., Christensen L., Behrens C., Freier S.M., Driver D.A., Berg R.H., Kim S.K., Norden B., and Nielsen P.E. PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature 365 (1993) 566-568
36. Fearon D.T., Carr J.M., Telaranta A., Carrasco M.J., and Thaventhiran J.E. The rationale for the IL-2-independent generation of the self-renewing central memory CD8+ T cells. Immunol. Rev. 211 (2006) 104-118
37. Fearon D.T., Manders P., and Wagner S.D. Arrested differentiation, the self-renewing memory lymphocyte, and vaccination. Science 293 (2001) 248-250
38. Fletcher J.M., Vukmanovic-Stejic M., Dunne P.J., Birch K.E., Cook J.E., Jackson S.E., Salmon M., Rustin M.H., and Akbar A.N. Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion. J. Immunol. 175 (2005) 8218-8225
39. Fritsch R.D., Shen X., Sims G.P., Hathcock K.S., Hodes R.J., and Lipsky P.E. Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27. J. Immunol. 175 (2005) 6489-6497
40. Gattinoni L., Klebanoff C.A., Palmer D.C., Wrzesinski C., Kerstann K., Yu Z., Finkelstein S.E., Theoret M.R., Rosenberg S.A., and Restifo N.P. Acquisition of full effector function in vitro, paradoxically impairs the in vivo anti-tumor efficacy of adoptively transferred CD8+ T cells. J. Clin. Invest. 115 (2005) 1616-1626
41. Gonzalez-Suarez E., Samper E., Flores J.M., and Blasco M.A. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat. Genet. 26 (2000) 114-117
42. Greider C.W. Telomere length regulation. Annu. Rev. Biochem. 65 (1996) 337-365
43. Hahn W.C., Counter C.M., Lundberg A.S., Beijersbergen R.L., Brooks M.W., and Weinberg R.A. Creation of human tumour cells with defined genetic elements. Nature 400 (1999) 464-468
44. Hahn W.C. Telomere and telomerase dynamics in human cells. Curr. Mol. Med. 5 (2005) 227-231
45. Hamann D., Kostense S., Wolthers K.C., Otto S.A., Baars P.A., Miedema F., and van Lier R.A. Evidence that human CD8 + CD45RA + CD27- cells are induced by antigen and evolve through extensive rounds of division. Int. Immunol. 11 (1999) 1027-1033
46. Harley C.B., Futcher A.B., and Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 345 (1990) 458-460
47. Harley C.B., Vaziri H., Counter C.M., and Allsopp R.C. The telomere hypothesis of cellular aging. Exp. Gerontol. 27 (1992) 375-382
48. Hathcock K.S., Jeffrey Chiang Y., and Hodes R.J. In vivo regulation of telomerase activity and telomere length. Immunol. Rev. 205 (2005) 104-113
49. Hayflick L., and Moorhead P.S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25 (1961) 585-621
50. Herbig U., Jobling W.A., Chen B.P., Chen D.J., and Sedivy J.M. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol. Cell 14 (2004) 501-513
51. Hiyama K., Hirai Y., Kyoizumi S., Akiyama M., Hiyama E., Piatyszek M.A., Shay J.W., Ishioka S., and Yamakido M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 155 (1995) 3711-3715
52. Hooijberg E., Ruizendaal J.J., Snijders P.J., Kueter E.W., Walboomers J.M., and Spits H. Immortalization of human CD8+ T cell clones by ectopic expression of telomerase reverse transcriptase. J. Immunol. 165 (2000) 4239-4245
53. Huang J., Khong H.T., Dudley M.E., El-Gamil M., Li Y.F., Rosenberg S.A., and Robbins P.F. Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression. J. Immunother. 28 (2005) 258-267
54. Jiang X.R., Jimenez G., Chang E., Frolkis M., Kusler B., Sage M., Beeche M., Bodnar A.G., Wahl G.M., Tlsty T.D., and Chiu C.P. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat. Genet. 21 (1999) 111-114
55. Kaech S.M., Tan J.T., Wherry E.J., Konieczny B.T., Surh C.D., and Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4 (2003) 1191-1198
56. Kedzierska K., La Gruta N.L., Turner S.J., and Doherty P.C. Establishment and recall of CD8+ T-cell memory in a model of localized transient infection. Immunol. Rev. 211 (2006) 133-145
57. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., Coviello G.M., Wright W.E., Weinrich S.L., and Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science 266 (1994) 2011-2015
58. Knudson M., Kulkarni S., Ballas Z.K., Bessler M., and Goldman F. Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenita. Blood 105 (2005) 682-688
59. Kolb H.J., Mittermuller J., Clemm C., Holler E., Ledderose G., Brehm G., Heim M., and Wilmanns W. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76 (1990) 2462-2465
60. Lansdorp P.M., Verwoerd N.P., van de Rijke F.M., Dragowska V., Little M.T., Dirks R.W., Raap A.K., and Tanke H.J. Heterogeneity in telomere length of human chromosomes. Hum. Mol. Genet. 5 (1996) 685-691
61. Lefrancois L. Development, trafficking, and function of memory T-cell subsets. Immunol. Rev. 211 (2006) 93-103
62. Liu K., Schoonmaker M.M., Levine B.L., June C.H., Hodes R.J., and Weng N.P. Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 5147-5152
63. Loughran Jr. T.P. Clonal diseases of large granular lymphocytes. Blood 82 (1993) 1-14
64. Luiten R.M., Pene J., Yssel H., and Spits H. Ectopic hTERT expression extends the life span of human CD4+ helper and regulatory T-cell clones and confers resistance to oxidative stress-induced apoptosis. Blood 101 (2003) 4512-4519
65. Maini M.K., Soares M.V., Zilch C.F., Akbar A.N., and Beverley P.C. Virus-induced CD8+ T cell clonal expansion is associated with telomerase up-regulation and telomere length preservation: a mechanism for rescue from replicative senescence. J. Immunol. 162 (1999) 4521-4526
66. Martens U.M., Zijlmans J.M., Poon S.S., Dragowska W., Yui J., Chavez E.A., Ward R.K., and Lansdorp P.M. Short telomeres on human chromosome 17p. Nat. Genet. 18 (1998) 76-80
67. Masutomi K., Possemato R., Wong J.M., Currier J.L., Tothova Z., Manola J.B., Ganesan S., Lansdorp P.M., Collins K., and Hahn W.C. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 8222-8227
68. McHeyzer-Williams M.G., and Davis M.M. Antigen-specific development of primary and memory T cells in vivo. Science 268 (1995) 106-111
69. Menzel O., Migliaccio M., Goldstein D.R., Dahoun S., Delorenzi M., and Rufer N. Mechanisms regulating the proliferative potential of human CD8+ T lymphocytes overexpressing telomerase. J. Immunol. 177 (2006) 3657-3668
70. Metcalfe J.A., Parkhill J., Campbell L., Stacey M., Biggs P., Byrd P.J., and Taylor A.M. Accelerated telomere shortening in ataxia telangiectasia. Nat. Genet. 13 (1996) 350-353
71. Migliaccio M., Amacker M., Just T., Reichenbach P., Valmori D., Cerottini J.C., Romero P., and Nabholz M. Ectopic human telomerase catalytic subunit expression maintains telomere length but is not sufficient for CD8+ T lymphocyte immortalization. J. Immunol. 165 (2000) 4978-4984
72. Monteiro J., Batliwalla F., Ostrer H., and Gregersen P.K. Shortened telomeres in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. J. Immunol. 156 (1996) 3587-3590
73. Morales C.P., Holt S.E., Ouellette M., Kaur K.J., Yan Y., Wilson K.S., White M.A., Wright W.E., and Shay J.W. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat. Genet. 21 (1999) 115-118
74. Moskophidis D., Lechner F., Pircher H., and Zinkernagel R.M. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362 (1993) 758-761
75. Narath R., Lorch T., Greulich-Bode K.M., Boukamp P., and Ambros P.F. Automatic telomere length measurements in interphase nuclei by IQ-FISH. Cytometry A 68 (2005) 113-120
76. Narita M., Nunez S., Heard E., Lin A.W., Hearn S.A., Spector D.L., Hannon G.J., and Lowe S.W. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113 (2003) 703-716
77. Nielsen P.E., Egholm M., Berg R.H., and Buchardt O. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 254 (1991) 1497-1500
78. Oehen S., Waldner H., Kundig T.M., Hengartner H., and Zinkernagel R.M. Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen. J. Exp. Med. 176 (1992) 1273-1281
79. Palmer L.D., Weng N., Levine B.L., June C.H., Lane H.C., and Hodes R.J. Telomere length, telomerase activity, and replicative potential in HIV infection: analysis of CD4+ and CD8+ T cells from HIV-discordant monozygotic twins. J. Exp. Med. 185 (1997) 1381-1386
80. Papagno L., Spina C.A., Marchant A., Salio M., Rufer N., Little S., Dong T., Chesney G., Waters A., Easterbrook P., Dunbar P.R., Shepherd D., Cerundolo V., Emery V., Griffiths P., Conlon C., McMichael A.J., Richman D.D., Rowland-Jones S.L., and Appay V. Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol. 2 (2004) 173-185
81. Pape K.A., Kearney E.R., Khoruts A., Mondino A., Merica R., Chen Z.M., Ingulli E., White J., Johnson J.G., and Jenkins M.K. Use of adoptive transfer of T-cell-antigen-receptor-transgenic T cell for the study of T-cell activation in vivo. Immunol. Rev. 156 (1997) 67-78
82. Plunkett F.J., Soares M.V., Annels N., Hislop A., Ivory K., Lowdell M., Salmon M., Rickinson A., and Akbar A.N. The flow cytometric analysis of telomere length in antigen-specific CD8+ T cells during acute Epstein-Barr virus infection. Blood 97 (2001) 700-707
83. Poon S.S., Martens U.M., Ward R.K., and Lansdorp P.M. Telomere length measurements using digital fluorescence microscopy. Cytometry 36 (1999) 267-278
84. Powell Jr. D.J., Dudley M.E., Robbins P.F., and Rosenberg S.A. Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy. Blood 105 (2005) 241-250
85. Reddel R.R. The role of senescence and immortalization in carcinogenesis. Carcinogenesis 21 (2000) 477-484
86. Reed J.R., Vukmanovic-Stejic M., Fletcher J.M., Soares M.V., Cook J.E., Orteu C.H., Jackson S.E., Birch K.E., Foster G.R., Salmon M., Beverley P.C., Rustin M.H., and Akbar A.N. Telomere erosion in memory T cells induced by telomerase inhibition at the site of antigenic challenge in vivo. J. Exp. Med. 199 (2004) 1433-1443
87. Rocha B., and Tanchot C. The Tower of Babel of CD8+ T-cell memory: known facts, deserted roads, muddy waters, and possible dead ends. Immunol. Rev. 211 (2006) 182-196
88. Romero P., Dunbar P.R., Valmori D., Pittet M., Ogg G.S., Rimoldi D., Chen J.L., Lienard D., Cerottini J.C., and Cerundolo V. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J. Exp. Med. 188 (1998) 1641-1650
89. Romero P., Valmori D., Pittet M.J., Zippelius A., Rimoldi D., Levy F., Dutoit V., Ayyoub M., Rubio-Godoy V., Michielin O., Guillaume P., Batard P., Luescher I.F., Lejeune F., Lienard D., Rufer N., Dietrich P.Y., Speiser D.E., and Cerottini J.C. Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma. Immunol. Rev. 188 (2002) 81-96
90. Romero P., Zippelius A., Kurth I., Pittet M.J., Touvrey C., Iancu E.M., Corthesy P., Devevre E., Speiser D.E., and Rufer N. Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J. Immunol. 178 (2007) 4112-4119
91. Rose M.G., and Berliner N. T-cell large granular lymphocyte leukemia and related disorders. Oncologist 9 (2004) 247-258
92. Roth A., Baerlocher G.M., Schertzer M., Chavez E., Duhrsen U., and Lansdorp P.M. Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT. Blood 106 (2005) 43-50
93. Roth A., Yssel H., Pene J., Chavez E.A., Schertzer M., Lansdorp P.M., Spits H., and Luiten R.M. Telomerase levels control the lifespan of human T lymphocytes. Blood 102 (2003) 849-857
94. Rufer N. Molecular tracking of antigen-specific T-cell clones during immune responses. Curr. Opin. Immunol. 17 (2005) 441-447
95. Rufer N., Brummendorf T.H., Kolvraa S., Bischoff C., Christensen K., Wadsworth L., Schulzer M., and Lansdorp P.M. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J. Exp. Med. 190 (1999) 157-167
96. Rufer N., Dragowska W., Thornbury G., Roosnek E., and Lansdorp P.M. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat. Biotechnol. 16 (1998) 743-747
97. Rufer N., Migliaccio M., Antonchuk J., Humphries R.K., Roosnek E., and Lansdorp P.M. Transfer of the human telomerase reverse transcriptase (TERT) gene into T lymphocytes results in extension of replicative potential. Blood 98 (2001) 597-603
98. Rufer N., Reichenbach P., and Romero P. Methods for the ex vivo characterization of human CD8+ T subsets based on gene expression and replicative history analysis. Methods Mol. Med. 109 (2005) 265-284
99. Rufer N., Zippelius A., Batard P., Pittet M.J., Kurth I., Corthesy P., Cerottini J.C., Leyvraz S., Roosnek E., Nabholz M., and Romero P. Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions. Blood 102 (2003) 1779-1787
100. Sallusto F., Geginat J., and Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22 (2004) 745-763
101. Sallusto F., Lenig D., Forster R., Lipp M., and Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401 (1999) 708-712
102. Sarin K.Y., Cheung P., Gilison D., Lee E., Tennen R.I., Wang E., Artandi M.K., Oro A.E., and Artandi S.E. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 436 (2005) 1048-1052
103. Schmid I., Dagarag M.D., Hausner M.A., Matud J.L., Just T., Effros R.B., and Jamieson B.D. Simultaneous flow cytometric analysis of two cell surface markers, telomere length, and DNA content. Cytometry 49 (2002) 96-105
104. Schreurs M.W., Scholten K.B., Kueter E.W., Ruizendaal J.J., Meijer C.J., and Hooijberg E. In vitro generation and life span extension of human papillomavirus type 16-specific, healthy donor-derived CTL clones. J. Immunol. 171 (2003) 2912-2921
105. Shen X., Zhou J., Hathcock K.S., Robbins P., Powell Jr. D.J., Rosenberg S.A., and Hodes R.J. Persistence of tumor infiltrating lymphocytes in adoptive immunotherapy correlates with telomere length. J. Immunother. 30 (2007) 123-129
106. Slijepcevic P. Telomere length measurement by Q-FISH. Methods Cell. Sci. 23 (2001) 17-22
107. Soares M.V., Plunkett F.J., Verbeke C.S., Cook J.E., Faint J.M., Belaramani L.L., Fletcher J.M., Hammerschmitt N., Rustin M., Bergler W., Beverley P.C., Salmon M., and Akbar A.N. Integration of apoptosis and telomere erosion in virus-specific CD8+ T cells from blood and tonsils during primary infection. Blood 103 (2004) 162-167
108. Speiser D.E., Baumgaertner P., Barbey C., Rubio-Godoy V., Moulin A., Corthesy P., Devevre E., Dietrich P.Y., Rimoldi D., Lienard D., Cerottini J.C., Romero P., and Rufer N. A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: spontaneous priming and efficient boosting by vaccination. J. Immunol. 177 (2006) 1338-1348
109. Speiser D.E., Migliaccio M., Pittet M.J., Valmori D., Lienard D., Lejeune F., Reichenbach P., Guillaume P., Luscher I., Cerottini J.C., and Romero P. Human CD8(+) T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells. Eur. J. Immunol. 31 (2001) 459-466
110. Surh C.D., Boyman O., Purton J.F., and Sprent J. Homeostasis of memory T cells. Immunol. Rev. 211 (2006) 154-163
111. van Baarle D., Tsegaye A., Miedema F., and Akbar A. Significance of senescence for virus-specific memory T cell responses: rapid ageing during chronic stimulation of the immune system. Immunol. Lett. 97 (2005) 19-29
112. Vaziri H., and Benchimol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8 (1998) 279-282
113. Vaziri H., Schachter F., Uchida I., Wei L., Zhu X., Effros R., Cohen D., and Harley C.B. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am. J. Hum. Genet. 52 (1993) 661-667
114. Walter E.A., Greenberg P.D., Gilbert M.J., Finch R.J., Watanabe K.S., Thomas E.D., and Riddell S.R. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333 (1995) 1038-1044
115. Weng N.P., Granger L., and Hodes R.J. Telomere lengthening and telomerase activation during human B cell differentiation. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 10827-10832
116. Weng N.P., Palmer L.D., Levine B.L., Lane H.C., June C.H., and Hodes R.J. Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging. Immunol. Rev. 160 (1997) 43-54
117. Weng N.P., Levine B.L., June C.H., and Hodes R.J. Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 11091-11094
118. Weng N.P., Levine B.L., June C.H., and Hodes R.J. Regulated expression of telomerase activity in human T lymphocyte development and activation. J. Exp. Med. 183 (1996) 2471-2479
119. Williams M.A., Holmes B.J., Sun J.C., and Bevan M.J. Developing and maintaining protective CD8+ memory T cells. Immunol. Rev. 211 (2006) 146-153
120. Wright W.E., and Shay J.W. Cellular senescence as a tumor-protection mechanism: the essential role of counting. Curr. Opin. Genet. Dev. 11 (2001) 98-103
121. Yang J., Chang E., Cherry A.M., Bangs C.D., Oei Y., Bodnar A., Bronstein A., Chiu C.P., and Herron G.S. Human endothelial cell life extension by telomerase expression. J. Biol. Chem. 274 (1999) 26141-26148
122. Yee C., Thompson J.A., Byrd D., Riddell S.R., Roche P., Celis E., and Greenberg P.D. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 16168-16173
123. Zhou J., Shen X., Huang J., Hodes R.J., Rosenberg S.A., and Robbins P.F. Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy. J. Immunol. 175 (2005) 7046-7052
124. Zippelius A., Pittet M.J., Batard P., Rufer N., de Smedt M., Guillaume P., Ellefsen K., Valmori D., Lienard D., Plum J., MacDonald H.R., Speiser D.E., Cerottini J.C., and Romero P. Thymic selection generates a large T cell pool recognizing a self-peptide in humans. J. Exp. Med. 195 (2002) 485-494